Literature DB >> 11535570

Effects of calcium, inorganic phosphate, and pH on isometric force in single skinned cardiomyocytes from donor and failing human hearts.

J van Der Velden1, L J Klein, R Zaremba, N M Boontje, M A Huybregts, W Stooker, L Eijsman, J W de Jong, C A Visser, F C Visser, G J Stienen.   

Abstract

BACKGROUND: During ischemia, the intracellular calcium and inorganic phosphate (P(i)) concentrations rise and pH falls. We investigated the effects of these changes on force development in donor and failing human hearts to determine if altered contractile protein composition during heart failure changes the myocardial response to Ca(2+), P(i), and pH. METHODS AND
RESULTS: Isometric force was studied in mechanically isolated Triton-skinned single myocytes from left ventricular myocardium. Force declined with added P(i) to 0.33+/-0.02 of the control force (pH 7.1, 0 mmol/L P(i)) at 30 mmol/L P(i) and increased with pH from 0.64+/-0.03 at pH 6.2 to 1.27+/-0.02 at pH 7.4. Force dependency on P(i) and pH did not differ between donor and failing hearts. Incubation of myocytes in a P(i)-containing activating solution caused a potentiation of force, which was larger at submaximal than at maximal [Ca(2+)]. Ca(2+) sensitivity of force was similar in donor hearts and hearts with moderate cardiac disease, but in end-stage failing myocardium it was significantly increased. The degree of myosin light chain 2 phosphorylation was significantly decreased in end-stage failing compared with donor myocardium, resulting in an inverse correlation between Ca(2+) responsiveness of force and myosin light chain 2 phosphorylation.
CONCLUSIONS: Our results indicate that contractile protein alterations in human end-stage heart failure alter Ca(2+) responsiveness of force but do not affect the force-generating capacity of the cross-bridges or its P(i) and pH dependence. In end-stage failing myocardium, the reduction in force by changes in pH and [P(i)] at submaximal [Ca(2+)] may even be less than in donor hearts because of the increased Ca(2+) responsiveness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535570     DOI: 10.1161/hc3501.095485

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  37 in total

1.  A novel, in-solution separation of endogenous cardiac sarcomeric proteins and identification of distinct charged variants of regulatory light chain.

Authors:  Sarah B Scruggs; Rick Reisdorph; Mike L Armstrong; Chad M Warren; Nichole Reisdorph; R John Solaro; Peter M Buttrick
Journal:  Mol Cell Proteomics       Date:  2010-05-05       Impact factor: 5.911

Review 2.  Mechanical and energetic consequences of HCM-causing mutations.

Authors:  Cecilia Ferrantini; Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Corrado Poggesi
Journal:  J Cardiovasc Transl Res       Date:  2009-10-09       Impact factor: 4.132

Review 3.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 4.  Disease proteomics toward bedside reality.

Authors:  Toshihide Nishimura; Atsushi Ogiwara; Kiyonaga Fujii; Takao Kawakami; Takeshi Kawamura; Hisae Anyouji; Harubumi Kato
Journal:  J Gastroenterol       Date:  2005-03       Impact factor: 7.527

Review 5.  Thick filament proteins and performance in human heart failure.

Authors:  Bradley M Palmer
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

6.  Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease.

Authors:  Farah Sheikh; Kunfu Ouyang; Stuart G Campbell; Robert C Lyon; Joyce Chuang; Dan Fitzsimons; Jared Tangney; Carlos G Hidalgo; Charles S Chung; Hongqiang Cheng; Nancy D Dalton; Yusu Gu; Hideko Kasahara; Majid Ghassemian; Jeffrey H Omens; Kirk L Peterson; Henk L Granzier; Richard L Moss; Andrew D McCulloch; Ju Chen
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

7.  Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium.

Authors:  Regis R Lamberts; Nazha Hamdani; Tenoedj W Soekhoe; Nicky M Boontje; Ruud Zaremba; Lori A Walker; Pieter P de Tombe; Jolanda van der Velden; Ger J M Stienen
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

8.  Identification of cardiac-specific myosin light chain kinase.

Authors:  Jason Y Chan; Morihiko Takeda; Laura E Briggs; Megan L Graham; Jonathan T Lu; Nobuo Horikoshi; Ellen O Weinberg; Hiroki Aoki; Naruki Sato; Kenneth R Chien; Hideko Kasahara
Journal:  Circ Res       Date:  2008-01-17       Impact factor: 17.367

9.  Skeletal muscle contractile protein function is preserved in human heart failure.

Authors:  Yoko Okada; Michael J Toth; Peter Vanburen
Journal:  J Appl Physiol (1985)       Date:  2008-01-17

10.  Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography.

Authors:  Charissa E van den Brom; Marc C Huisman; Ronald Vlasblom; Nicky M Boontje; Suzanne Duijst; Mark Lubberink; Carla F M Molthoff; Adriaan A Lammertsma; Jolanda van der Velden; Christa Boer; D Margriet Ouwens; Michaela Diamant
Journal:  Cardiovasc Diabetol       Date:  2009-07-22       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.